ArticleArthritis research & therapy2022

Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis.

Ryosuke Fukue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.